Yukako Yamamoto

Possibility of switching from liraglutide to oral hypoglycemic agents as a useful therapeutic option for obese Japanese type 2 diabetics

M. Iwanishi, Choka Azuma, Yuji Tezuka, 2018 .

A Prospective, Open-Label Short-Term Pilot Study on Modification of the Skin Hydration Status During Treatment With a Sodium-Glucose Cotransporter-2 Inhibitor

A. Kashiwagi, A. Shimatsu, M. Iwanishi, 2020, Diabetes Therapy.

Observation of p.R4810K, a Polymorphism of the Mysterin Gene, the Susceptibility Gene for Moyamoya Disease, in Two Female Japanese Diabetic Patients with Familial Partial Lipodystrophy 1

T. Kusakabe, Shingo Kikugawa, M. Iwanishi, 2020, Internal medicine.

Effects of a new 75 g glucose- and high fat-containing cookie meal test on postprandial glucose and triglyceride excursions in morbidly obese patients.

T. Kitamura, Masaki Kobayashi, Atsunori Kashiwagi, 2022, Endocrine journal.

A Sodium-Glucose Cotransporter-2 Inhibitor Modulates the Skin Hydration State in Type 2 Diabetes Patients: Post-Hoc Analysis of a Prospective, Open-Label Pilot Study

A. Kashiwagi, A. Shimatsu, M. Iwanishi, 2021 .

Clinical characteristics in two patients with partial lipodystrophy and Type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene.

T. Kusakabe, K. Ebihara, M. Iwanishi, 2019, Diabetes research and clinical practice.

A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon‐derived peptide levels

Y. Hayashi, T. Kitamura, Masaki Kobayashi, 2023, Journal of diabetes investigation.

Antidepressant-like effect of food-derived pyroglutamyl peptides in mice

T. Mizushige, Kousaku Ohinata, Takafumi Mizushige, 2015, Neuropeptides.